Browsing: Pharmaceuticals

The war in Iran has pushed up the price of widely used medicines in England, including painkillers and hay fever medication, leading pharmacists have warned.Community chemists…

The US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if ministers agree to regularly increase NHS drug prices…

Syngenta is to build a new £100m research centre for agricultural bioscience, a move hailed by the government as a vote of confidence in the UK’s…

Recent coverage of the pipeline of new antibiotics (Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn, 11 March) is a timely reminder…

The pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have said, predicting the…

The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.Novo Nordisk’s…

The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in revenues this year owing to a push by Donald Trump to lower…

The UK has agreed to pay 25% more for new medicines by 2035 as part of a US-UK drug pricing deal that will cost an estimated…

The UK science minister has said officials are “working day and night” trying to resolve the standoff with big pharmaceutical companies over drug pricing.Speaking to industry…

‘We want to see more investment flow to Britain,” the chancellor, Rachel Reeves, urged of big pharmaceutical companies this month, as she indicated that the government…